GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » Cyclically Adjusted PB Ratio

EXMceuticals (FRA:9OM1) Cyclically Adjusted PB Ratio : (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


EXMceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for EXMceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Cyclically Adjusted PB Ratio Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of EXMceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EXMceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where EXMceuticals's Cyclically Adjusted PB Ratio falls into.



EXMceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

EXMceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2021 is calculated as:

For example, EXMceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2021 was:

Adj_Book=Book Value per Share/CPI of Mar. 2021 (Change)*Current CPI (Mar. 2021)
=-0.014/110.2976*110.2976
=-0.014

Current CPI (Mar. 2021) = 110.2976.

EXMceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201106 0.110 94.654 0.128
201109 0.109 95.286 0.126
201112 0.103 94.970 0.120
201203 0.102 96.155 0.117
201206 0.059 96.076 0.068
201209 0.055 96.392 0.063
201212 0.048 95.760 0.055
201303 0.048 97.103 0.055
201306 0.040 97.182 0.045
201309 0.037 97.419 0.042
201312 0.032 96.945 0.036
201403 0.027 98.604 0.030
201406 0.020 99.473 0.022
201409 0.018 99.394 0.020
201412 0.015 98.367 0.017
201503 0.010 99.789 0.011
201506 0.018 100.500 0.020
201509 0.016 100.421 0.018
201512 0.011 99.947 0.012
201603 0.007 101.054 0.008
201606 0.002 102.002 0.002
201609 0.001 101.765 0.001
201612 0.000 101.449 0.000
201703 -0.001 102.634 -0.001
201706 -0.005 103.029 -0.005
201709 -0.003 103.345 -0.003
201712 -0.002 103.345 -0.002
201803 0.005 105.004 0.005
201806 0.006 105.557 0.006
201809 -0.022 105.636 -0.023
201812 0.063 105.399 0.066
201903 0.010 106.979 0.010
201906 0.009 107.690 0.009
201909 -0.009 107.611 -0.009
201912 -0.028 107.769 -0.029
202003 -0.059 107.927 -0.060
202006 -0.111 108.401 -0.113
202009 -0.007 108.164 -0.007
202012 -0.012 108.559 -0.012
202103 -0.014 110.298 -0.014

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EXMceuticals  (FRA:9OM1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


EXMceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (FRA:9OM1) Business Description

Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines